Related Experiment Video
Updated: Nov 30, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
The challenge of clinical adoption-the insurmountable obstacle that will stop machine learning?
Jonathan Taylor1, John Fenner2
1Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Abstract:
Machine learning promises much in the field of radiology, both in terms of software that can directly analyse patient data and algorithms that can automatically perform other processes in the reporting pipeline. However, clinical practice remains largely untouched by such technology. This article highlights what we consider to be the major obstacles to widespread clinical adoption of machine learning software, namely: representative data and evidence, regulations, health economics, heterogeneity of the clinical environment and support and promotion. We argue that these issues are currently so substantial that machine learning will struggle to find acceptance beyond the narrow group of applications where the potential benefits are readily evident. In order that machine learning can fulfil its potential in radiology, a radical new approach is needed, where significant resources are directed at reducing impediments to translation rather than always being focused solely on development of the technology itself.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
04:04Asthma Detection Research Based on Voice Signal Processing and Machine Learning
Published on: July 22, 2025
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Clinical Trials
There are four phases in a clinical trial. A phase one...